Free public records show Changchun GeneScience Pharmaceutical Co., Ltd. in 4 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Changchun GeneScience Pharmaceutical Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
49 active studies led by Changchun GeneScience Pharmaceutical Co., Ltd., of 111 in all
Source: ClinicalTrials.gov, Studies with Changchun GeneScience Pharmaceutical Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Changchun GeneScience Pharmaceutical Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Changchun GeneScience Pharmaceutical Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Changchun GeneScience Pharmaceutical Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Changchun GeneScience Pharmaceutical Co., Ltd. is in.
Stories on the topics Changchun GeneScience Pharmaceutical Co., Ltd. works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
ReadSearch all reports for Changchun GeneScience Pharmaceutical Co., Ltd. All companies